<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">NIZATIDINE</span><br/>(ni-za'ti-deen)<br/><span class="topboxtradename">Axid, </span><span class="topboxtradename">Axid AR<br/></span><b>Classifications:</b> <span class="classification">gastrointestinal agent</span>; <span class="classification">antisecretory (h<sub>2</sub>-receptor antagonist)</span><br/><b>Prototype: </b>Cimetidine<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>75 mg tablets; 150 mg, 300 mg capsules; 15 mg/mL oral solution</p>
<h1><a name="action">Actions</a></h1>
<p>Inhibits secretion of gastric acid by reversible, competitive blockage of histamine at the H<sub>2</sub> receptor, particularly those in the gastric parietal cells.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Significantly reduces nocturnal gastric acid secretion for up to 12 h.</p>
<h1><a name="uses">Uses</a></h1>
<p>Active duodenal ulcers; maintenance therapy for duodenal ulcers.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to nizatidine; lactation; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Hypersensitivity to other H<sub>2</sub>-receptor antagonists; renal impairment or renal failure; older adults; pregnancy (category B).
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Active Duodenal Ulcer</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 150 mg b.i.d. or 300 mg h.s.<br/><br/><span class="indicationtitle">Maintenance Therapy</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 150 mg h.s.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give drug usually once daily at bedtime. Dose may be divided and given twice daily.</li>
<li>Administer oral liquid drug using a calibrated measuring device.</li>
<li>Be aware that antacids consisting of aluminum and magnesium hydroxides with simethicone decrease nizatidine absorption by
            about 10%. Administer the antacid 2 h after nizatidine.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Somnolence, fatigue. <span class="typehead">Skin:</span> Pruritus, sweating. <span class="typehead">Metabolic:</span> Hyperuricemia. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May decrease absorption of <b>delavirdine,</b> <b>didanosine,</b> <b>itraconazole,</b> <b>ketoconazole;</b> <span class="classification">antacid</span>s may decrease absorption of nizatidine. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> &gt;90% absorbed from GI tract. <span class="typehead">Peak:</span> 0.53 h. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> 60% excreted in urine unchanged. <span class="typehead">Half-Life:</span> 12 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor patient for alleviation of symptoms. Most ulcers should heal within 4 wk.</li>
<li>Monitor cardiac patient's apical pulse because asymptomatic ventricular tachycardia is an adverse effect of the drug.</li>
<li>Monitor for persistence of ulcer symptoms in patients who continue to smoke during therapy.</li>
<li>Lab tests: Monitor liver enzyme studies (AST, ALT) and alkaline phosphatase. Nizatidine may cause hepatocellular injury.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take medications for the full course of therapy even though symptoms may be relieved.</li>
<li>Do not take other prescription or OTC medications without consulting physician.</li>
<li>Stop smoking; smoking adversely affects healing of ulcers and effectiveness of the drug.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>